Cargando…

Effects of weight management by exercise modes on markers of subclinical atherosclerosis and cardiometabolic profile among women with abdominal obesity: a randomized controlled trial

BACKGROUND: Few studies have examined the differential effects of weight management by exercise mode on subclinical atherosclerosis. We hypothesized that 3 modes of aerobic, resistance, and combination exercises have differential effects on the flow-mediated dilation (FMD), carotid-femoral pulse wav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choo, Jina, Lee, Juneyoung, Cho, Jeong-Hyun, Burke, Lora E, Sekikawa, Akira, Jae, Sae Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105524/ https://www.ncbi.nlm.nih.gov/pubmed/25011384 http://dx.doi.org/10.1186/1471-2261-14-82

Ejemplares similares

Gender differences in health-related quality of life associated with abdominal obesity in a Korean population
por: Choo, Jina, et al.
Publicado: (2014)

Comparison of Predictive Value of Cardiometabolic Indices for Subclinical Atherosclerosis in Chinese Adults
por: Xu, Ying, et al.
Publicado: (2014)

Normal-weight obesity is associated with increased risk of subclinical atherosclerosis
por: Kim, Sohee, et al.
Publicado: (2015)

Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects
por: Moreno, María, et al.
Publicado: (2014)

Role of Surrogate Markers of Atherosclerosis in Clinical and Subclinical Thyroidism
por: Gunduz, Mehmet, et al.
Publicado: (2012)

Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes
por: Aydın, Kadriye, et al.
Publicado: (2016)

Markers of Subclinical Atherosclerosis in Severe Obesity and One Year after Bariatric Surgery
por: Kovac, Nina, et al.
Publicado: (2022)

Variants of PCSK9 Gene Are Associated with Subclinical Atherosclerosis and Cardiometabolic Parameters in Mexicans. The GEA Project
por: Zamarrón-Licona, Erasmo, et al.
Publicado: (2021)

Effects of the Healthy Children, Healthy Families, Healthy Communities Program for Obesity Prevention among Vulnerable Children: A Cluster-Randomized Controlled Trial
por: Choo, Jina, et al.
Publicado: (2020)

Relation between Birth Weight, Growth, and Subclinical Atherosclerosis in Adulthood
por: Valente, Maria Helena, et al.
Publicado: (2015)

Insulin metabolism markers are predictors of subclinical atherosclerosis among overweight and obese children and adolescents
por: Asghari, Golaleh, et al.
Publicado: (2018)

Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive
por: Recio-Rodriguez, Jose I, et al.
Publicado: (2012)

Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2023)

Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice?
por: Katsiki, Niki, et al.
Publicado: (2017)

Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism
por: Yasar, Hamiyet Yilmaz, et al.
Publicado: (2019)

Inflammatory Markers Used as Predictors of Subclinical Atherosclerosis in Patients with Diabetic Polyneuropathy
por: Mureșan, Adrian Vasile, et al.
Publicado: (2023)

Risk Factors for Subclinical Atherosclerosis in Diabetic and Obese Children
por: Faienza, Maria Felicia, et al.
Publicado: (2013)

Subclinical Atherosclerosis and Obesity Phenotypes Among Mexican Americans
por: Laing, Susan T., et al.
Publicado: (2015)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women
por: Harada, Paulo H. N., et al.
Publicado: (2017)

Impact of hypertension on various markers of subclinical atherosclerosis in early type 2 diabetes
por: Alatab, Sudabeh, et al.
Publicado: (2014)

Allantoin as an independent marker associated with carotid intima-media thickness in subclinical atherosclerosis
por: Santana, M.S., et al.
Publicado: (2018)

Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis—The IMPROVE Study
por: Coggi, Daniela, et al.
Publicado: (2021)

Sleep Irregularity and Subclinical Markers of Cardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
por: Full, Kelsie M., et al.
Publicado: (2023)

Lifetime cigarette smoking is associated with abdominal obesity in a community-based sample of Japanese men: The Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA)
por: Fujiyoshi, Akira, et al.
Publicado: (2016)

Eicosanoids: Atherosclerosis and cardiometabolic health
por: Piper, Kimberly, et al.
Publicado: (2020)

Weight Change and Its Association with Cardiometabolic Risk Markers in Overweight and Obese Women
por: Ahmad Zamri, Liyana, et al.
Publicado: (2020)

Subclinical carotid atherosclerosis predicts all-cause mortality and cardiovascular events in obese patients with negative exercise echocardiography
por: Vidal-Perez, Rafael, et al.
Publicado: (2019)

Subclinical Atherosclerosis, Vascular Risk Factors, and White Matter Alterations in Diffusion Tensor Imaging Findings of Older Adults With Cardiometabolic Diseases
por: Tamura, Yoshiaki, et al.
Publicado: (2021)

Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults
por: Li, Zhibin, et al.
Publicado: (2020)

Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity
por: Carmona-Maurici, Júlia, et al.
Publicado: (2023)

Noninvasive indicators of atherosclerosis in subclinical hypothyroidism
por: Kilic, Ismail Dogu, et al.
Publicado: (2013)

Association of Fat Density With Subclinical Atherosclerosis
por: Alvey, Nicholas J., et al.
Publicado: (2014)

Subclinical atherosclerosis: how and when to treat it?
por: Gatto, Laura, et al.
Publicado: (2020)

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Kaiser, Hannah, et al.
Publicado: (2021)

Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis
por: D'Abramo, Alessandra, et al.
Publicado: (2014)

Associations of kidney injury markers with subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis
por: Park, Meyeon, et al.
Publicado: (2015)

Marker of endothelial dysfunction may improve the early detection of insulin resistance and subclinical atherosclerosis
por: de Almeida Pititto, Bianca, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o3jm3sliu3bii4g5suuok4oa8s